Description
Moxifloxacin and Prednisolone Ophthalmic Suspension is available in the market under the brand name of Abimox-PD in 5 ml bottles with tamper-evident caps. Individually Moxifloxacin and Prednisolone Ophthalmic Suspension are packed in mono cartons with a comprehensive product insert. Moxifloxacin and Prednisolone Ophthalmic Suspension is a formulation designed to comprehensively treat inflammation and infection. Moxifloxacin and Prednisolone Ophthalmic Suspension is a combination of two medicines, Moxifloxacin and Prednisolone.
Moxifloxacin and Prednisolone Ophthalmic Suspension is a reliable solution for treating eye infection that causes inflammation. The combined antibiotic and anti-inflammation is a powerful, easy-to-use formula. The result and easy-to-use dosage make it a must-have in any ophthalmic product range.
Usage and Dosage for Moxifloxacin and Prednisolone Ophthalmic Suspension
It has different usage and dosage for each condition separately, for example
- Bacterial infection: 1-2 drops into the affected eye four times daily for a minimum of 10 days
- Post operation inflammation and infection prophylaxis: 1-2 drops, 4-6 times daily fora minimum of 10 days
- Anterior uveitis: 1-2 drops every 1-2 hours initially, then 4-6 times daily
- Allergic conjunctivitis: 1 drop 3 -4 times daily
Advantages of Using Moxifloxacin and Prednisolone Ophthalmic Suspension
This dual-action formula effectively uses the strong antibacterial properties of moxifloxacin with the powerful anti-inflammation of prednisolone. Making it the best option for conjunctivitis and other eye conditions that involve inflammation and infections.
- Dual therapeutic action: The combination of two wonderful medicines together Moxifloxacin and Prednisolon,e makes it more effective
- Enhance clinical compliance: this formulation reduces the need for multiple eye drops, thus increasing the patient’s awareness in receiving and following the treatment protocol
- Rapid Symptom relief: Fast action helps relieve the redness, swelling pain.
- Stable formulation: minimal wastage, well tolerated and high shelf life.
Regulatory and Quality Compliance
Moxifloxacin and Prednisolone Ophthalmic Suspension is manufactured under WHO-GMP facilities following strict quality assurance protocol.
We also ensure that our packaging, labelling, and documentation are fully compliant with regulatory guidelines, making the Moxifloxacin and Prednisolone Ophthalmic Suspension solution ready to use in both domestic and international distribution in the market.
Precautions to Consider
- Avoid in viral of fungal infection: This drop is not suitable for viral infection as steroids can increase worsen the condition
- Not for long-term use: Long-term use of Moxifloxacin and Prednisolone Ophthalmic Suspension can increase the IOP; regular monitoring is good.
- Avoid contact lenses: during the use of Moxifloxacin and Prednisolone Ophthalmic Suspension, take off the contact lens and keep at least 15 15-minute gap between putting in back.
- Avoid sudden discontinuation: after prolonged use, sudden withdrawal may cause inflammation and irritation
